Nanobodies can be used to detect atherosclerosis risk

04/9/2012 | MedPage Today (free registration)

French researchers have developed nanobodies that can attach to vascular cell adhesion molecule-1, which is linked to the development of atherosclerosis, according to a study published in Circulation Research. The nanobodies can be tagged with technetium-99m and imaged through SPECT, according to the study. Researchers said SPECT also identified human and mouse cross-reactive labeled VCAM-1, indicating that the nanobodies can be used in the clinical setting.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC